Blank Cover Image

Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects

フォーマット:
論文
責任表示:
Ohtani, Rumiko ; Inazu, Akihiro ; Noji, Yoshihiro ; Wakasugi, Takanobu ; Miwa, Kenji ; Tada, Hayato ; Kawashiri, Masa-aki ; Noguchi, Tohru ; Nohara, Atsushi ; Kobayashi, Junji ; Koizumi, Junji ; Yamagishi, Masakazu ; Mabuchi, Hiroshi
言語:
英語
出版情報:
Elsevier BV, 2012-03-22
著者名:
Ohtani, Rumiko
Inazu, Akihiro
Noji, Yoshihiro
Wakasugi, Takanobu
Miwa, Kenji
Tada, Hayato
Kawashiri, Masa-aki
Noguchi, Tohru
Nohara, Atsushi
Kobayashi, Junji
Koizumi, Junji
Yamagishi, Masakazu
Mabuchi, Hiroshi
続きを見る
掲載情報:
Clinica Chimica Acta
ISSN:
0009-8981  CiNii Research  Webcat Plus  JAIRO
巻:
413
通号:
5-6
開始ページ:
537
終了ページ:
543
バージョン:
author
概要:
Thesis of Ohtani, Rumiko / 大谷 留珠子 博士学位論文(金沢大学 / 大学院医薬保健学総合研究科)<br />Background: The half of hyperalphalipoproteinemia (HALP) in Japan is caused by CETP gene mutations. Other than two prevalent mutations (D442G and Intron 14 splicing d onor site +. 1G>A), some rare CETP mutations are found in Japanese HALP subjects. Methods: CETP gene analysis of genomic DNA from subjects was performed by restriction fragment length polymorphism (RFLP) and sequencing analysis. Mutations which were suspected to cause a splicing defect or a protein secretion defect were investigated in COS-1 cells transfected with a CETP minigene construct or a cDNA expression vector. Results: Each of three subjects was identified as a carrier of CETP gene mutation of a compound heterozygote of c.653_654delGGinsAAAC and Intron 14 splicing donor site +. 1G>A, a heterozygote of c.658G>A or a homozygote of L261R. The c.658G>A mutation was located at the last nucleotide of exon 7, and it was confirmed to cause splicing abnormality revealed by the CETP minigene analysis. The L261R CETP was not secreted to conditioned media of the cells. Conclusions: Three novel CETP gene mutations are responsible for HALP by CETP deficiency. It is predicted that there are more rare CETP gene mutations in Japanese, and these multiple rare mutations alone or a combination with each of prevalent mutations is responsible for mild-to-moderate or marked HALP, respectively. © 2011 Elsevier B.V. 続きを見る
URL:
http://hdl.handle.net/2297/30540
タイトル・著者・出版者が同じ資料

類似資料:

1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 

Tada, Hayato, Kawashiri, Masa-aki, Ohtani, Rumiko, Noguchi, Tohru, Nakanishi, Chiaki, Konno, Tetsuo, Hayashia, Kenshi, &hellip;

Elsevier Science Ireland

Noguchi, Tohru, Kobayashi, Junji, Yagi, Kunimasa, Nohara, Atsushi, Yamaaki, Naoto, Sugihara, Masako, Ito, Naoko, Oka, &hellip;

Elsevier Ireland Ltd

Tada, Hayato, Kawashiri, Masa-aki, Ohtani, Rumiko, Noguchi, Tohru, Nakanishi, Chiaki, Konno, Tetsuo, Hayashi, Kenshi, &hellip;

Elsevier

Tada, Hayato, Kawashiri, Masaaki, Noguchi, Tohru, Mori, Mika, Tsuchida, Masayuki, Takata, Mutsuko, Nohara, Atsushi, &hellip;

Elsevier

Tada, Hayato, Kawashiri, Masa-aki, Ohtani, Rumiko, Noguchi, Tohru, Nakanishi, Chiaki, Konno, Tetsuo, Hayashi, Kenshi, &hellip;

Elsevier

Tada, Hayato, Kawashiri, Masa-aki, Okada, Hirofumi, Teramoto, Ryota, Konno, Tetsuo, Yoshimuta, Tsuyoshi, Sakata, Kenji, &hellip;

Elsevier

Mabuchi, Hiroshi, Nohara, Atsushi, Noguchi, Tohru, Kobayashi, Junji, Kawashiri, Masa-aki, Tada, Hayato, Nakanishi, &hellip;

Elsevier

Nozue, Tsuyoshi, Higashikata, Toshinori, Inazu, Akihiro, Kawashiri, Masa-aki, Nohara, Atsushi, Kobayashi, Junji, &hellip;

Japanese Society of Internal Medicine = 日本内科学会

Mabuchi, Hiroshi, Nohara, Atsushi, Noguchi, Tohru, Kobayashi, Junji, Kawashiri, Masaaki, Tada, Hayato, Nakanishi, &hellip;

Elsevier

大谷, 留珠子, Ohtani, Rumiko

金沢大学大学院医薬保健学総合研究科保健学専攻博士後期課程 / 金沢大学

Tada, Hayato, Kobayashi, Junji, Kawashiri, Masa-aki, Miyashita, Kazuya, Nohara, Atsushi, Inazu, Akihiro, Nakajima, &hellip;

BioMed Central

Tsuchida, Masayuki, Kawashiri, Masa-aki, Tada, Hayato, Takata, Mutsuko, Nohara, Atsushi, Ino, Hidekazu, Inazu, Akihiro, &hellip;

Japanese Circulation Society = 日本循環器学会